dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.contributorUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2022-11-30T13:45:12Z
dc.date.accessioned2022-12-20T14:50:49Z
dc.date.available2022-11-30T13:45:12Z
dc.date.available2022-12-20T14:50:49Z
dc.date.created2022-11-30T13:45:12Z
dc.date.issued2022-07-29
dc.identifierDermatology And Therapy. Northcote: Adis Int Ltd, v. 12, n. 9, p. 1989-2012, 2022.
dc.identifier2193-8210
dc.identifierhttp://hdl.handle.net/11449/237797
dc.identifier10.1007/s13555-022-00780-4
dc.identifierWOS:000832846100003
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5417853
dc.description.abstractMelasma is a prevalent chronic relapsing pigmentary disorder that affects photoexposed areas, especially in women of childbearing age. Although there is currently no curative treatment available for melasma, this manuscript critically reviews the knowledge regarding photoprotection, topical and oral therapies, and procedures such as peelings, laser, and microneedling that represent the main strategies for control and prevention of this disease. As the pathogenesis of melasma is not entirely understood, there are prospects for the development of new therapeutic strategies that might act on the pathways that promote sustained pigmentation rather than merely decreasing melanin synthesis and removing melanin from the epidermis.
dc.languageeng
dc.publisherAdis Int Ltd
dc.relationDermatology And Therapy
dc.sourceWeb of Science
dc.subjectMelasma
dc.subjectPeeling
dc.subjectSunscreen
dc.subjectUV radiation
dc.subjectLaser
dc.titleUpdate on Melasma-Part II: Treatment
dc.typeOtros


Este ítem pertenece a la siguiente institución